Werkgroep Cardiologische centra Nederland

SAVOR TIMI53 (Completed)

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications
Medicine
saxagliptine
Population
Diabetes mellitus
Phase
IV
Starting year
2010
More information
ClinicalTrials.gov

Director of Study

dr. B.E. Groenemeijer (Cardioloog)
Apeldoorn, Gelre Ziekenhuizen

SAVOR TIMI53: News